Tiny coils improve quality of life for patients with severe emphysema
(University of Pittsburgh Schools of the Health Sciences) Results from a large international trial were presented by researchers from the University of Pittsburgh School of Medicine at the American Thoracic Society International Meeting in San Francisco. Minimally invasive implantation of tiny coils into the lungs improves exercise ability, lung function and quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 15, 2016 Category: Global & Universal Source Type: news
Tobacco products, e-cigarettes come under greater regulation
The U.S. Food and Drug Administration (FDA) Thursday took an important step in the national regulation of tobacco products, issuing a new rule that prohibits the sale of a number of tobacco products, including e-cigarettes, to minors. But two provisions in a federal bill could significantly weaken this authority. Find out what the FDA rule says and how it could be already under threat.
“Before today, there was no federal law prohibiting retailers from selling e-cigarettes, hookah tobacco or cigars to people under age 18,” the FDA said in a news release. “Today’s rule changes that with provisions aimed at restrict...
Source: AMA Wire - May 5, 2016 Category: Journals (General) Authors: Troy Parks Source Type: news
Medical Errors May Be Third Leading Cause Of Death In America
BOSTON (CBS) – Researchers say medical mistakes should be listed as the third leading cause of death in the United States.
The study, led by a Johns Hopkins surgeon, estimates that more than 250,000 Americans die each year from unrecognized surgical complications or medication mix-ups. They say the Centers for Disease Control that ranks causes of deaths every year, does not take into account medical mistakes.
Death certificates often list the cause of death as a patient’s underlying diagnosis whether it’s heart disease or colon cancer or emphysema. But the researchers argue that doctors should also be as...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 4, 2016 Category: Consumer Health News Authors: deanreddington Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Centers For Disease Control Dr. Mallika Marshall Source Type: news
Making Pharma Personal
Paul Perreault, CEO and Managing Director of biotherapies company CSL Behring, often receives messages from people celebrating the great landmarks in their lives. There is nothing so very extraordinary about that – except these are from patients whom he has helped during his time in the business.
“I wasn’t always an executive, so I started in the business, and I know patients and their families personally, across the country,” he begins. “At different levels of jobs that I’ve had in the organization, I’ve interacted with patients on a very direct and one-on-one level. And I was around when there were shortage...
Source: EyeForPharma - April 28, 2016 Category: Pharmaceuticals Authors: Adam Hill Source Type: news
Study finds shared network of genes in COPD and pulmonary fibrosis
Research on chronic lung diseases has primarily focused on studying conditions, such as emphysema or lung fibrosis, in isolation. In a new study, Yale scientists identified a common genetic network for two chronic lung diseases that could inform both future research and drug development. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 22, 2016 Category: Universities & Medical Training Tags: Yale News Source Type: news
Giving Emphysema Patients a Chance to Breathe
(Source: MDDI)
Source: MDDI - April 15, 2016 Category: Medical Equipment Authors: MDDI Staff Tags: Business Medical Device Business Source Type: news
Endobronchial Valve Treatment for Severe Emphysema Endobronchial Valve Treatment for Severe Emphysema
Dr Shorr provides a literature update by discussing the STELVIO trial, which tested bronchoscopic endobronchial-valve treatment in patients with severe emphysema without collateral ventilation. Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2016 Category: Consumer Health News Tags: Pulmonary Medicine Commentary Source Type: news
Coronary Artery Disease and Emphysema in HIV+ PatientsCoronary Artery Disease and Emphysema in HIV+ Patients
What is the relationship between coronary artery disease and emphysema in patients with HIV infection? HIV Medicine (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - March 30, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news
Rare respiratory disease gene carriers actually have increased lung function
New research has revealed the healthy carriers of a gene that causes a rare respiratory disease are taller and larger than average, with greater respiratory capacity. The disease, alpha1-antitrypsin deficiency can result in severely reduced lung capacity due to emphysema. It is found in about 1 in 2,000 people, and occurs when an individual inherits a defective gene copy from both parents. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 4, 2016 Category: Science Source Type: news
Rare respiratory disease gene carriers actually have increased lung function
New research has revealed the healthy carriers of a gene that causes a rare respiratory disease are taller and larger than average, with greater respiratory capacity.
The disease, alpha1-antitrypsin deficiency (AATD) can result in severely reduced lung capacity due to emphysema. It is found in about 1 in 2,000 people, and occurs when an individual inherits a defective gene copy from both parents. (Source: University of Bristol news)
Source: University of Bristol news - March 4, 2016 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, School of Social and Community Medicine, Institutes, Elizabeth Blackwell; Press Release Source Type: news
Rare respiratory disease gene carriers actually have increased lung function
(University of Bristol) New research has revealed the healthy carriers of a gene that causes a rare respiratory disease are taller and larger than average, with greater respiratory capacity.The disease, alpha1-antitrypsin deficiency can result in severely reduced lung capacity due to emphysema. It is found in about 1 in 2,000 people, and occurs when an individual inherits a defective gene copy from both parents. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 4, 2016 Category: Biology Source Type: news
Long-term aspirin use linked to lower risk of gastrointestinal tract cancers
Study showed 15% lower risk of gastrointestinal cancer and 19% lower risk of cancers of the colon and rectumRelated items from OnMedicaPros of daily aspirin outweigh cons for cutting digestive tract cancer riskBenefits of taking aspirin highest in women aged 65 plusRegular aspirin use may slow progression of early emphysema Aspirin boosts cancer immunotherapy, study showsAspirin trialled to see if it prevents cancer recurrence (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 4, 2016 Category: UK Health Source Type: news
Uptake Medical touts InterVapor study results indicating improved lung function
Uptake Medical said today that data from a study recently published in the journal Lancet indicated that patients who underwent therapy using the company’s InterVapor system experienced statistically significant benefits in both lung function and quality of life.
The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said.
The results are from the company’s Step-Up randomized, controlled, multi-center, multi-national study designed to evaluate the safety and performance of its Intervapor system.
“Non-surgical bronchoscopi...
Source: Mass Device - March 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Respiratory Uptake Medical Source Type: news
Exposure to air pollution 30 years ago associated with increased risk of death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research. Highest risks were seen for respiratory disease, such as bronchitis, emphysema and for pneumonia. Air pollution also affected mortality risk from cardiovascular diseases, such as heart disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2016 Category: Science Source Type: news
Study: Nicotine Patch Works as Well as Chantix to Help Quit Smoking
This study confirms that FDA-approved medications are effective in helping smokers quit,” said Lee Westmaas, PhD, American Cancer Society director of tobacco control research. “Smokers should seriously consider using medications if they are finding it difficult to quit without any help. The most effective approach to quitting is using medications in combination with counseling such as from a quit-line.”RESOURCES: How to Quit Smoking Quit-smoking medicationsResearch shows that using a medication to help you quit smoking can double your chances of being successful.The US Food and Drug Administr...
Source: American Cancer Society :: News and Features - February 2, 2016 Category: Cancer & Oncology Tags: Smoking/Tobacco Source Type: news
